« Previous
Next »
Titles
- Alternative policies for pricing novel vaccines and drug therapies for COVID-191
- Alternative pricing models for remdesivir and other potential treatments for COVID-191
- Alternative procedures for blood and blood components during the COVID-19 public health emergency1
- America's hidden common ground on the coronavirus crisis: results from a Public Agenda/USA Today/Ipsos survey of Americans' views on reopening their communities1
- Anesthesia services: differences between private and Medicare payments likely due to providers' strong negotiating position : report to Congressional committees1
- Antibiotic resistance: additional federal actions needed to better determine magnitude and reduce impact1
- Approaches to making practice and system changes to improve patient and family engagement: 12 ways hospitals integrate family caregiver support1
- Are older nontraditional workers able to find health and retirement coverage?1
- Are there enough experienced physicians to treat patients hospitalized with COVID?1
- Arizona: Latino children's health coverage facts1
- Arkansas Medicaid Fraud Control Unit: 2019 onsite inspection1
- As it grows, Medicare Advantage is enrolling more low-income and medically complex beneficiaries: recent trends in beneficiary clinical characteristics, health care utilization, and spending1
- Assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical trials of drugs and biological products for COVID-19 prevention or treatment1
- Assessing user fees under the Biosimilar User Fee Amendments of 20171
- Assessing user fees under the prescription drug user fee amendments of 20171